Hsp90 Activity Modulation by Plant Secondary Metabolites

Abstract Hsp90 is an evolutionarily conserved adenosine triphosphate-dependent molecular chaperone and is one of the most abundant proteins in the cells (1–3 %). Hsp90 is induced when a cell undergoes various types of environmental stresses such as heat, cold, or oxygen deprivation. It is involved in the turnover, trafficking, and activity of client proteins, including apoptotic factors, protein kinases, transcription factors, signaling proteins, and a number of oncoproteins. Most of the Hsp90 client proteins are involved in cell growth, differentiation, and survival, and include kinases, nuclear hormone receptors, transcription factors, and other proteins associated with almost all the hallmarks of cancer. Consistent with these diverse activities, genetic and biochemical studies have demonstrated the implication of Hsp90 in a range of diseases, including cancer, making this chaperone an interesting target for drug research. During the last few decades, plant secondary metabolites have been studied as a major source for lead compounds in drug discovery. Recently, several plant-derived small molecules have been discovered exhibiting inhibitory activity towards Hsp90, such as epigallocatechin gallate, gedunin, lentiginosine, celastrol, and deguelin. In this work, an overview of plant secondary metabolites interfering with Hsp90 activities is provided.

[1]  D. Tang,et al.  Comparative investigation of in vitro biotransformation of 14 components in Ginkgo biloba extract in normal, diabetes and diabetic nephropathy rat intestinal bacteria matrix. , 2014, Journal of pharmaceutical and biomedical analysis.

[2]  P. Ismail,et al.  Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer. , 2014, European journal of pharmacology.

[3]  C. Ramos,et al.  The effect of celastrol, a triterpene with antitumorigenic activity, on conformational and functional aspects of the human 90kDa heat shock protein Hsp90α, a chaperone implicated in the stabilization of the tumor phenotype. , 2014, Biochimica et biophysica acta.

[4]  E. Bae,et al.  Inhibition of adipocyte inflammation and macrophage chemotaxis by butein. , 2014, European journal of pharmacology.

[5]  R. Bhat,et al.  Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors. , 2014, Journal of medicinal chemistry.

[6]  S. Paul,et al.  Identifying a C-terminal ATP binding sites-based novel Hsp90-Inhibitor in silico: a plausible therapeutic approach in Alzheimer's disease. , 2014, Medical hypotheses.

[7]  L. Luo,et al.  Luteolin is effective in the non‐small cell lung cancer model with L858R/T790M EGF receptor mutation and erlotinib resistance , 2014, British journal of pharmacology.

[8]  Y. Seo,et al.  Synthesis of Butein Analogues and their Anti-proliferative Activity Against Gefitinib-resistant Non-small Cell Lung Cancer (NSCLC) through Hsp90 Inhibition , 2014 .

[9]  G. Chiosis,et al.  Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions , 2014, Expert opinion on investigational drugs.

[10]  Aykut Ozgur and Yusuf Tutar Heat Shock Protein 90 Inhibitors in Oncology , 2014 .

[11]  Jianxing He,et al.  Celastrol Induces Apoptosis in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells via Caspases-Dependent Pathways and Hsp90 Client Protein Degradation , 2014, Molecules.

[12]  R. Cotugno,et al.  Bioactive limonoids from the leaves of Azaridachta indica (Neem). , 2014, Journal of natural products.

[13]  Jun Ye,et al.  Celastrol Induces Apoptosis of Gastric Cancer Cells by miR-21 Inhibiting PI3K/Akt-NF-κB Signaling Pathway , 2014, Pharmacology.

[14]  C. Chi,et al.  Andrographolide downregulates the v-Src and Bcr-Abl oncoproteins and induces Hsp90 cleavage in the ROS-dependent suppression of cancer malignancy. , 2014, Biochemical pharmacology.

[15]  L. Luo,et al.  Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages. , 2014, Biochemical and biophysical research communications.

[16]  Y. Seo,et al.  Synthesis of Flavokawain B and Its anti‐Proliferative Activity Against Gefitinib‐Resistant Non‐Small Cell Lung Cancer (NSCLC). , 2013 .

[17]  Y. Seo Butein Disrupts Hsp90's Molecular Chaperoning Function and Exhibits Anti-proliferative Effects Against Drug-resistant Cancer Cells , 2013 .

[18]  A. Leone,et al.  Identification of the Plant Compound Geraniin as a Novel Hsp90 Inhibitor , 2013, PloS one.

[19]  J. Patki,et al.  HSP90: Chaperone-me-not , 2013, Pathology & Oncology Research.

[20]  Jia Li,et al.  Geraniin induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro and in vivo. , 2013, Canadian journal of physiology and pharmacology.

[21]  S. Guan,et al.  ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3β in the signal network , 2013, Cell Death and Disease.

[22]  Jie Liu,et al.  Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy , 2013, Neurochemistry International.

[23]  J. Park,et al.  Geraniin down regulates gamma radiation-induced apoptosis by suppressing DNA damage. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  Chih-Yang Huang,et al.  Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition , 2013, Evidence-based complementary and alternative medicine : eCAM.

[25]  X. Zi,et al.  Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis , 2013, Molecular Cancer.

[26]  Agostino Casapullo,et al.  Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor. , 2013, Chemical communications.

[27]  C. Garrido,et al.  Targeting heat shock proteins in cancer. , 2013, Cancer letters.

[28]  Y. Ikeda,et al.  Non-Specific Protein Modifications by a Phytochemical Induce Heat Shock Response for Self-Defense , 2013, PloS one.

[29]  H. Matsunaga,et al.  Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors. , 2013, Analytical biochemistry.

[30]  G. Bifulco,et al.  A chemical-biological study reveals C9-type iridoids as novel heat shock protein 90 (Hsp90) inhibitors. , 2013, Journal of medicinal chemistry.

[31]  G. Su,et al.  Proteomic analysis of the effect of triterpenes from Patrinia heterophylla on leukemia K562 cells. , 2012, Journal of ethnopharmacology.

[32]  Shufeng Zhou,et al.  Mechanism of reversal of high glucose-induced endothelial nitric oxide synthase uncoupling by tanshinone IIA in human endothelial cell line EA.hy926. , 2012, European journal of pharmacology.

[33]  Biplab Bhattacharjee,et al.  Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[34]  L. Luo,et al.  Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3 , 2012, PloS one.

[35]  A. Vassallo,et al.  Biflavonoids from Daphne linearifolia Hart. , 2012 .

[36]  G. Bifulco,et al.  Natural Iminosugar (+)-Lentiginosine Inhibits ATPase and Chaperone Activity of Hsp90 , 2012, PloS one.

[37]  N. Grammatikakis,et al.  Cell Surface Cdc37 Participates in Extracellular HSP90 Mediated Cancer Cell Invasion , 2012, PloS one.

[38]  E. Wattenberg,et al.  Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog. , 2012, Biochemical and biophysical research communications.

[39]  F. Villarreal,et al.  (-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT , 2012, Molecular and Cellular Biochemistry.

[40]  A. Gomes,et al.  Black tea polyphenols induce human leukemic cell cycle arrest by inhibiting Akt signaling , 2012, The FEBS journal.

[41]  X. Zi,et al.  Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[42]  Haihua Feng,et al.  Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. , 2012, Journal of agricultural and food chemistry.

[43]  Hsueh-Wei Chang,et al.  Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo. , 2012, The Journal of nutritional biochemistry.

[44]  T. Zhu,et al.  β-Elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells , 2012, Journal of Neuro-Oncology.

[45]  Lianfeng Zhang,et al.  Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo. , 2012, Bioorganic & medicinal chemistry letters.

[46]  J. Stanslas,et al.  Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer , 2012, Clinical and experimental pharmacology & physiology.

[47]  G. Bifulco,et al.  Structural characterization of tetranortriterpenes from Pseudrocedrela kotschyi and Trichilia emetica and study of their activity towards the chaperone Hsp90. , 2012, Phytochemistry.

[48]  K. Subbaramaiah,et al.  Carnosol, a Constituent of Zyflamend, Inhibits Aryl Hydrocarbon Receptor–Mediated Activation of CYP1A1 and CYP1B1 Transcription and Mutagenesis , 2012, Cancer Prevention Research.

[49]  M. Lilly,et al.  Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice , 2012, PloS one.

[50]  M. Motilva,et al.  Metabolic pathways of the colonic metabolism of flavonoids (flavonols, flavones and flavanones) and phenolic acids , 2012 .

[51]  Paul Workman,et al.  Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? , 2012, Clinical Cancer Research.

[52]  Ming Zhao,et al.  Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90 , 2011, Molecular Cancer.

[53]  Zhe-Sheng Chen,et al.  Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu. , 2011, Molecular pharmaceutics.

[54]  C. Hunt,et al.  Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins. , 2011, Bioorganic & medicinal chemistry.

[55]  G. Sethi,et al.  Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways , 2011, Apoptosis.

[56]  Weimin Zhao Introduction to Natural Products Chemistry , 2011 .

[57]  I. Warner,et al.  Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro. , 2011, Chemico-biological interactions.

[58]  P. Oliveira,et al.  Berberine as a promising safe anti-cancer agent - is there a role for mitochondria? , 2011, Current drug targets.

[59]  B. Blagg,et al.  Gambogic acid, a natural product inhibitor of Hsp90. , 2011, Journal of natural products.

[60]  Xiaodan Yu,et al.  Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells , 2011, BMC Cancer.

[61]  A. Kinghorn,et al.  Absolute configuration of (-)-gambogic acid, an antitumor agent. , 2011, Journal of natural products.

[62]  S. Ni,et al.  Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. , 2011, Cancer letters.

[63]  M. Rogosnitzky,et al.  Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions , 2011 .

[64]  Si-Yang Song,et al.  Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells. , 2010, Biochemical and biophysical research communications.

[65]  M. Konopleva,et al.  Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma , 2010, British Journal of Cancer.

[66]  Taher Abbasi,et al.  Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo , 2010, Clinical Cancer Research.

[67]  Shu-mei Lin,et al.  Butein downregulates phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in cancerous and non-cancerous breast cells. , 2010, European journal of pharmacology.

[68]  G. Sethi,et al.  Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells. , 2010, Biochemical pharmacology.

[69]  Erin E. Carlson,et al.  Natural products as chemical probes. , 2010, ACS chemical biology.

[70]  P. Chueh,et al.  Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: Involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells. , 2010, Free radical biology & medicine.

[71]  Sang‐Gun Ahn,et al.  Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo , 2010, BMC Cancer.

[72]  Chunxin Yang,et al.  Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way , 2010, Cell Stress and Chaperones.

[73]  Bi-Fong Lin,et al.  Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian) , 2010, Chinese medicine.

[74]  Lin Qiu,et al.  Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation. , 2010, Cancer letters.

[75]  G. Uzan,et al.  HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way , 2010, Molecular Cancer.

[76]  A. Salminen,et al.  Celastrol: Molecular targets of Thunder God Vine. , 2010, Biochemical and biophysical research communications.

[77]  S. Shukla,et al.  Apigenin: A Promising Molecule for Cancer Prevention , 2010, Pharmaceutical Research.

[78]  Q. Dou,et al.  Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells. , 2010, International journal of molecular medicine.

[79]  J. Holzbeierlein,et al.  Hsp90: A Drug Target? , 2010, Current oncology reports.

[80]  M. Ramirez-Alvarado,et al.  Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23* , 2009, The Journal of Biological Chemistry.

[81]  U. Testa,et al.  Triterpenoids as new promising anticancer drugs. , 2009, Anti-cancer drugs.

[82]  S. Tsao,et al.  Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. , 2009, Journal of ethnopharmacology.

[83]  Tao Zhang,et al.  Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction* , 2009, The Journal of Biological Chemistry.

[84]  A. Aura,et al.  Tannins: current knowledge of food sources, intake, bioavailability and biological effects. , 2009, Molecular nutrition & food research.

[85]  H. Schwalbe,et al.  Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. , 2009, Angewandte Chemie.

[86]  Tao Zhang,et al.  (-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2. , 2009, Molecular pharmaceutics.

[87]  W. Wong,et al.  A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-kb Pathway , 2022 .

[88]  H. Canatan,et al.  In vitro and in vivo anti-inflammatory effects of andrographolide. , 2009, International immunopharmacology.

[89]  J. M. Kim,et al.  5,7‐dihydroxy‐3,4,6‐trimethoxyflavone inhibits the inflammatory effects induced by Bacteroides fragilis enterotoxin via dissociating the complex of heat shock protein 90 and IκBα and IκB kinase‐γ in intestinal epithelial cell culture , 2009, Clinical and experimental immunology.

[90]  Tao Zhang,et al.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. , 2009, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[91]  S. Kwon,et al.  Anti-cancer effect of Betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem Mass Spectrometry. , 2009, Planta medica.

[92]  T. Gasiewicz,et al.  (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. , 2009, Biochemistry.

[93]  J. Reynolds,et al.  The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down‐regulating the expression of heat shock protein 90 , 2008, The Prostate.

[94]  K. Subbaramaiah,et al.  Heat Shock Protein 90 Inhibitors Suppress Aryl Hydrocarbon Receptor–Mediated Activation of CYP1A1 and CYP1B1 Transcription and DNA Adduct Formation , 2008, Cancer Prevention Research.

[95]  B. Blagg,et al.  Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships. , 2008, Journal of medicinal chemistry.

[96]  I. Merfort,et al.  Anti-Oxidant, Anti-Inflammatory and Anti-Allergic Activities of Luteolin , 2008, Planta medica.

[97]  Y. Kwon,et al.  Quercetin‐induced ubiquitination and down‐regulation of Her‐2/neu , 2008, Journal of cellular biochemistry.

[98]  I. Merfort,et al.  Anti-carcinogenic Effects of the Flavonoid Luteolin , 2008, Molecules.

[99]  Winston Yu-Chen Chen,et al.  Molecular Simulation of HER2/neu Degradation by Inhibiting HSP90 , 2008 .

[100]  B. Blagg,et al.  Synthesis and evaluation of derrubone and select analogues. , 2008, The Journal of organic chemistry.

[101]  Tao Zhang,et al.  A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells , 2008, Molecular Cancer Therapeutics.

[102]  J. Gestwicki,et al.  Derrubone, an inhibitor of the Hsp90 protein folding machinery. , 2007, Journal of natural products.

[103]  S. Fu,et al.  Suppression of v-Src Transformation by Andrographolide via Degradation of the v-Src Protein and Attenuation of the Erk Signaling Pathway* , 2007, Journal of Biological Chemistry.

[104]  G. Williams,et al.  A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[105]  T. Ceremuga,et al.  Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. , 2007, AANA journal.

[106]  L. Marnett,et al.  Identification of the protein targets of the reactive metabolite of teucrin A in vivo in the rat. , 2007, Chemical research in toxicology.

[107]  B. Aggarwal,et al.  Butein, a Tetrahydroxychalcone, Inhibits Nuclear Factor (NF)-κB and NF-κB-regulated Gene Expression through Direct Inhibition of IκBα Kinase β on Cysteine 179 Residue* , 2007, Journal of Biological Chemistry.

[108]  Di Chen,et al.  A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. , 2007, Cancer research.

[109]  E. A. Rogozin,et al.  Direct Inhibition of Insulin-Like Growth Factor-I Receptor Kinase Activity by (−)−Epigallocatechin-3-Gallate Regulates Cell Transformation , 2007, Cancer Epidemiology Biomarkers & Prevention.

[110]  A. Martineau,et al.  Quercetin, Siamois 1 and siamois 2 induce apoptosis in human breast cancer MDA-MB-435 cells xenograft in vivo , 2007, Cancer biology & therapy.

[111]  Xianglin Shi,et al.  Chrysin inhibits expression of hypoxia-inducible factor-1α through reducing hypoxia-inducible factor-1α stability and inhibiting its protein synthesis , 2007, Molecular Cancer Therapeutics.

[112]  T. Golub,et al.  Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.

[113]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[114]  R. Xu,et al.  [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine]. , 2006, Zhonghua yi xue za zhi.

[115]  Neal Rosen,et al.  Hsp90: a novel target for cancer therapy. , 2006, Current topics in medicinal chemistry.

[116]  Di Chen,et al.  Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. , 2006, Cancer research.

[117]  S. Lindquist,et al.  HSP90 and the chaperoning of cancer , 2005, Nature Reviews Cancer.

[118]  R. Keast,et al.  Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil , 2005, Nature.

[119]  P. Murphy,et al.  Human gut microbial degradation of flavonoids: structure-function relationships. , 2005, Journal of agricultural and food chemistry.

[120]  T. Gasiewicz,et al.  Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. , 2005, Biochemistry.

[121]  D. Sohn,et al.  Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells. , 2004, Biochemical and biophysical research communications.

[122]  S. Imaoka,et al.  Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF‐1α protein , 2004, FEBS letters.

[123]  Z. Darżynkiewicz,et al.  Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. , 2004, Biochemical and biophysical research communications.

[124]  Hong Zhang,et al.  Targeting multiple signal transduction pathways through inhibition of Hsp90 , 2004, Journal of Molecular Medicine.

[125]  K. Itoh,et al.  Role of Intestinal Flora on the Metabolism, Absorption, and Biological Activity of Dietary Flavonoids , 2003 .

[126]  J. Kanner,et al.  Antioxidant and prooxidant effects of phenolics on pancreatic β-cells in vitro , 2002 .

[127]  Y. Surh,et al.  Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human promyelocytic leukemia cells. , 2001, Mutation research.

[128]  L. Neckers,et al.  The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the Chaperone* , 2000, The Journal of Biological Chemistry.

[129]  Steiner Gg The correlation between cancer incidence and kava consumption. , 2000 .

[130]  S. Shibata,et al.  A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. , 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[131]  Hui-Kang Wang The therapeutic potential of flavonoids , 2000, Expert opinion on investigational drugs.

[132]  L. Pearl,et al.  Structure and in vivo function of Hsp90. , 2000, Current opinion in structural biology.

[133]  J. Buchner,et al.  The Hsp90 complex--a super-chaperone machine as a novel drug target. , 1998, Biochemical pharmacology.

[134]  A. Nakai,et al.  Quercetin suppresses heat shock response by down regulation of HSF1. , 1995, Biochemical and biophysical research communications.

[135]  I. Kapétanidis,et al.  Flavonoids from Iochroma gesnerioides. , 1994, Pharmaceutica Acta Helvetiae.

[136]  J. Medina,et al.  Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea , 1994, Pharmacology Biochemistry and Behavior.

[137]  E. Middleton,et al.  Effects of flavonoids on immune and inflammatory cell functions. , 1992, Biochemical pharmacology.

[138]  A. Elbein,et al.  Lentiginosine, a dihydroxyindolizidine alkaloid that inhibits amyloglucosidase. , 1990, Biochemistry.

[139]  T. Hatano,et al.  Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. , 1988, Chemical & pharmaceutical bulletin.

[140]  B. Henderson,et al.  Cancer incidence in the islands of the Pacific. , 1985, National Cancer Institute monograph.

[141]  T. Mabry,et al.  Antibacterial activity studies of flavonoids from Salvia palaestina. , 1983, Journal of natural products.

[142]  E. Paulus,et al.  Condensed tannins. 10. Isolation of (--)-butin and butein from wattle heartwoods. , 1961, The Biochemical journal.

[143]  R. Jahan,et al.  A review on berbamine a - a potential anticancer drug. , 2014 .

[144]  Zheng,et al.  Blockade of Her 2 / neu binding to Hsp 90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her 2 / neu , 2012 .

[145]  B. Blagg,et al.  The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derrubone. , 2010, Bioorganic & medicinal chemistry.

[146]  Yun‐Sil Lee,et al.  Celastrol binds to ERK and inhibits FcεRI signaling to exert an anti-allergic effect , 2009 .

[147]  B. Aggarwal,et al.  Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. , 2007, The Journal of biological chemistry.

[148]  Ou Qiao-ming Studies on chemical constituents from Patrinia heterophylla Bunge. and their cytotoxicity in vitro , 2007 .

[149]  S. Shukla,et al.  Apigenin and cancer chemoprevention: progress, potential and promise (review). , 2007, International journal of oncology.

[150]  L. Neckers Chaperoning oncogenes: Hsp90 as a target of geldanamycin. , 2006, Handbook of experimental pharmacology.

[151]  S. Kimura,et al.  Inhibition of leukemic cell growth by a novel anti‐cancer drug (GUT‐70) from calophyllum brasiliense that acts by induction of apoptosis , 2005, International journal of cancer.

[152]  Woo-Kyu Park,et al.  Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. , 2004, Pharmacological research.

[153]  G. Steiner The correlation between cancer incidence and kava consumption. , 2000, Hawaii medical journal.

[154]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.

[155]  M. Gábor Anti-inflammatory and anti-allergic properties of flavonoids. , 1986, Progress in clinical and biological research.

[156]  R. E. Wheeler,et al.  Natural occurrence of 3-aryl-4-hydroxycoumarins. Part I. Phytochemical examination of Derris robusta(roxb.) benth. , 1969 .

[157]  D. Hathway The Condensed Tannins , 1962 .